XML 23 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
Note 8 - Segments
9 Months Ended
Sep. 30, 2022
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]

NOTE 8 SEGMENTS

 

The Company has determined its operating segments in accordance with ASC 280 Segment Reporting. Factors used to determine the Company’s reportable segments include the availability of separate financial statements, the existence of locally based leadership across geographic regions, the economic factors affecting each segment, and the evaluation of operating results at the segment level. The Chief Operating Decision Maker (“CODM”) allocates the Company’s resources for each of the operating segments and evaluates their relative performance. Each operating segment listed below has separate financial statements and locally based leadership that are evaluated based on the results of their respective segments. It should be noted that the operating segments below have different products and services. The financial information is condensed consolidated and evaluated regularly by the CODM in assessing performance and allocating resources.

 

The Company has four reportable segments: Helomics, zPREDICTA, Soluble and Skyline. See discussion of revenue recognition in Note 1 – Summary of Significant Accounting Policies for a description of the products and services recognized in each segment. The segment revenues and segment net losses for the three and nine months ended September 30, 2022 and 2021 are included in the table below. All revenues are earned from external customers.

 

Revenue

 

  

Three Months Ended

September 30,

  

Nine Months Ended,

September 30,

 
  2022  2021  2022  2021 

Helomics

 $1,821  $2,164  $5,543  $11,314 

Soluble

  29,439   27,653   64,580   76,639 

zPREDICTA

  170,816   -   261,099    

Skyline

  253,751   282,675   809,875   853,063 

Corporate

  -   1,171   889   3,171 

Total

 $455,827  $313,663  $1,141,986  $944,187 

 

Segment Gain (Loss)

 

  

Three Months Ended

September 30,

  

Nine Months Ended,

September 30,

 
  2022  2021  2022  2021 

Helomics

 $(916,113) $(3,739,275) $(2,902,182) $(6,024,129)

Soluble

  (407,622)  (352,324)  (1,206,550)  (840,790)

zPREDICTA

  (160,395)  -   (7,989,585)  - 

Skyline

  (109,408)  (102,850)  (259,444)  (378,490)

Corporate

  (2,465,946)  (1,243,568)  (5,463,763)  (4,657,253)

Total

 $(4,059,484) $(5,438,017) $(17,821,524) $(11,900,662)

 

Assets

 

  

As of

September 30,

  

As of

December 31,

 
  

2022

  

2021

 

Helomics

 $1,061,545  $1,802,792 

Soluble

  1,559,917   1,742,445 

zPREDICTA

  3,815,513   10,782,568 

Skyline

  15,046,253   906,977 

Corporate

  11,682,981   28,536,489 

Total

 $33,166,209  $43,771,271